These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32750445)

  • 1. Novel hybrid compounds, opioid agonist+melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of neuropathic pain.
    Starnowska-Sokół J; Piotrowska A; Bogacka J; Makuch W; Mika J; Witkowska E; Godlewska M; Osiejuk J; Gątarz S; Misicka A; Przewłocka B
    Neuropharmacology; 2020 Nov; 178():108232. PubMed ID: 32750445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel bifunctional hybrid compounds designed to enhance the effects of opioids and antagonize the pronociceptive effects of nonopioid peptides as potent analgesics in a rat model of neuropathic pain.
    Piotrowska A; Starnowska-Sokół J; Makuch W; Mika J; Witkowska E; Tymecka D; Ignaczak A; Wilenska B; Misicka A; Przewłocka B
    Pain; 2021 Feb; 162(2):432-445. PubMed ID: 32826750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.
    Starnowska J; Costante R; Guillemyn K; Popiolek-Barczyk K; Chung NN; Lemieux C; Keresztes A; Van Duppen J; Mollica A; Streicher J; Vanden Broeck J; Schiller PW; Tourwé D; Mika J; Ballet S; Przewlocka B
    ACS Chem Neurosci; 2017 Oct; 8(10):2315-2324. PubMed ID: 28699350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral antinociceptive effects of MC4 receptor antagonists in a rat model of neuropathic pain - a biochemical and behavioral study.
    Starowicz K; Mousa SA; Obara I; Chocyk A; Przewłocki R; Wedzony K; Machelska H; Przewłocka B
    Pharmacol Rep; 2009; 61(6):1086-95. PubMed ID: 20081244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of melanocortin-induced changes in spinal nociception by mu-opioid receptor agonist and antagonist in neuropathic rats.
    Starowicz K; Przewlocki R; Gispen WH; Przewlocka B
    Neuroreport; 2002 Dec; 13(18):2447-52. PubMed ID: 12499847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores.
    Witkowska E; Godlewska M; Osiejuk J; Gątarz S; Wileńska B; Kosińska K; Starnowska-Sokół J; Piotrowska A; Lipiński PFJ; Matalińska J; Dyniewicz J; Halik PK; Gniazdowska E; Przewlocka B; Misicka A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.
    Vrinten DH; Gispen WH; Groen GJ; Adan RA
    J Neurosci; 2000 Nov; 20(21):8131-7. PubMed ID: 11050135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain.
    Vrinten DH; Gispen WH; Kalkman CJ; Adan RA
    Anesthesiology; 2003 Aug; 99(2):449-54. PubMed ID: 12883419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain.
    Bertorelli R; Fredduzzi S; Tarozzo G; Campanella M; Grundy R; Beltramo M; Reggiani A
    Behav Brain Res; 2005 Feb; 157(1):55-62. PubMed ID: 15617771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of spinally administered bifunctional nociceptin/orphanin FQ peptide receptor/μ-opioid receptor ligands in mouse models of neuropathic and inflammatory pain.
    Sukhtankar DD; Zaveri NT; Husbands SM; Ko MC
    J Pharmacol Exp Ther; 2013 Jul; 346(1):11-22. PubMed ID: 23652222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stronger antinociceptive efficacy of opioids at the injured nerve trunk than at its peripheral terminals in neuropathic pain.
    Labuz D; Machelska H
    J Pharmacol Exp Ther; 2013 Sep; 346(3):535-44. PubMed ID: 23820126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and TRPV1 in the peripheral control of neuropathic pain--Defining a target site in the injured nerve.
    Labuz D; Spahn V; Celik MÖ; Machelska H
    Neuropharmacology; 2016 Feb; 101():330-40. PubMed ID: 26453963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain.
    Lagard C; Chevillard L; Guillemyn K; Risède P; Laplanche JL; Spetea M; Ballet S; Mégarbane B
    Pain; 2017 Mar; 158(3):505-515. PubMed ID: 28135212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
    Tzschentke TM; Linz K; Frosch S; Christoph T
    Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HS014, a selective melanocortin-4 (MC4) receptor antagonist, modulates the behavioral effects of morphine in mice.
    Ercil NE; Galici R; Kesterson RA
    Psychopharmacology (Berl); 2005 Jul; 180(2):279-85. PubMed ID: 15719225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.
    Ciapała K; Rojewska E; Pawlik K; Ciechanowska A; Mika J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.
    Largent-Milnes TM; Yamamoto T; Nair P; Moulton JW; Hruby VJ; Lai J; Porreca F; Vanderah TW
    Br J Pharmacol; 2010 Nov; 161(5):986-1001. PubMed ID: 20977451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
    Front Immunol; 2021; 12():781310. PubMed ID: 34795678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain.
    Holdridge SV; Cahill CM
    Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.